RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$327M
AUM Growth
-$10.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$7.18M
2
+$6.87M
3
+$6.41M
4
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$4.4M
5
ALKS icon
Alkermes
ALKS
+$4.2M

Top Sells

1
+$11.5M
2
+$8.22M
3
+$7.28M
4
BIIB icon
Biogen
BIIB
+$6.95M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.58M

Sector Composition

1 Healthcare 82.32%
2 Financials 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$11.4M 3.34%
266,000
+98,000
2
$10.3M 3.02%
98,700
+68,700
3
$9.62M 2.82%
58,000
-35,000
4
$9.59M 2.81%
29,000
-21,000
5
$8.44M 2.47%
54,000
+10,507
6
$7.66M 2.24%
72,000
-108,000
7
$7.58M 2.22%
80,000
-76,781
8
$6.87M 2.01%
+133,800
9
$6.64M 1.94%
92,000
-58,000
10
$6.58M 1.93%
76,000
-95,000
11
$6.41M 1.88%
+111,000
12
$6.13M 1.8%
33,867
+16,534
13
$5.96M 1.75%
49,000
+16,000
14
$5.82M 1.71%
224,000
+157,000
15
$5.73M 1.68%
72,000
+22,000
16
$5.42M 1.59%
219,000
-11,000
17
$5.41M 1.58%
55,900
+42,900
18
$5.25M 1.54%
107,000
-26,000
19
$5.07M 1.48%
99,000
+14,000
20
$4.83M 1.41%
43,000
-58,600
21
$4.83M 1.41%
20,000
-5,000
22
$4.6M 1.35%
13,000
-9,500
23
$4.46M 1.31%
38,000
-17,000
24
$4.42M 1.29%
59,000
-40,000
25
$4.4M 1.29%
+18,600
1
2 3 4 5